Blood pressure heart rate double control
Today we talk about blood pressure and heart rate management for kidney patients. In practice, for patients with kidneys, treatment is not limited to treatment of kidneys, but the heart is also closely monitored. Many patients diagnosed as CKD may be accompanied by diseases such as hypertension, and there is a certain basis for heart and kidney differences. According to the data, there may be 72.4 per cent of CKD patients who know that they have high blood pressure, and then those who know that they have it will also have treatment interventions of more than two thirds, while only a small percentage of those who have control of blood pressure after treatment, let alone a heart rate of less than 80 according to our guidelines. Seeing such a low amount of data, there’s a question in everyone’s mind. Why is it being treated or not well controlled? First of all, let us understand the relationship between the two diseases. The ckd sufferers, because of the decrease in the GFR, can cause autonomous nervous disorders in our bodies, while sodium retention, some of the internal skin functions are impaired, and blood-ureic acid can rise at any time, thus increasing blood pressure and, at the same time, the risk of cardiovascular disease due to electrolyte disorders in our kidneys. The human body is inherently a body that works closely together to maintain the balance in our body, and the kidneys and the heart, which are two important organs in our body, are broken when problems arise. In the case of CKD patients who have already experienced problems, which have been combined with hypertension, we are actively seeking treatment to keep their blood pressure and heart rate in the normal range as soon as possible, thereby slowing down the incidence of diseases such as renal reduction and urine poisoning. It is generally hoped that blood pressure will be kept below 140/90, that older persons may be below 150/90 and that the heart rate will be better under 80. Often to help patients lose their blood pressure, kidneys are also used in combination with several types of depressive drugs, including ARB, CCB, β-receptor retardants, urinants, etc. The use of β-receptor retardants is also increasing after several generations of drug upgrades. The β-receptor retardants themselves can control the heart rate and have pressure relief, but long-term use of the found increase in the patient ‘ s heart load, reduction in renal infusion and urine sodium excretion, and increased insulin resistance, so that the latest generation of β-receptor retardants not only reduces the associated side effects by adding a little a-reception retardation, but also increases the effect of the depressure, which is also appropriate for CKD patients at different times, and still helps patients to reduce blood pressure and stabilize their heart rate. Drug control, of course, is only one aspect of treatment, and we also need to manage life styles, diets, moods, etc., and internal and external combinations to achieve blood pressure and heart rate.
